Global Breast Cancer Market Size, Share, and COVID-19 Impact Analysis, By Cancer Type (Hormone Receptor, HER2+), By Therapy (Targeted Therapy, Hormonal Therapy, Surgery & Radiation Therapy, Biologic Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, & Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032

Industry: Healthcare

RELEASE DATE Apr 2023
REPORT ID SI1743
PAGES 200
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Cancer Type
      2. Market Attractiveness Analysis by Therapy
      3. Market Attractiveness Analysis by Distribution Channel
      4. Market Attractiveness Analysis by Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising incidences
    3. Restraints
      1. High cost of treatment
    4. Opportunities
      1. The development of new drugs
    5. Challenges
      1. Limited Access to Healthcare
  6. Global Breast Cancer Market Analysis and Projection, By Cancer Type
    1. Segment Overview
    2. Hormone Receptor
    3. HER2+
  7. Global Breast Cancer Market Analysis and Projection, By Therapy
    1. Targeted Therapy
    2. Hormonal Therapy
    3. Surgery and Radiation Therapy
    4. Biologic Therapy
  8. Global Breast Cancer Market Analysis and Projection, By Distribution Channel
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    4. Others
  9. Global Breast Cancer Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Breast Cancer Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Breast Cancer Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Bristol Myers Squiib
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. KYOWA KIRIN
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Eisai Co. Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. Sanofi
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.  Pfizer Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Genentech
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Mylan Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Celltrion
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.   Fresenuis Kabi
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Baxter Healthcare Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.    Halozyme Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.    GlaxoSmithKline
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15.     AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

Recent Developments

SWOT Analysis

List of Table

  1. Global Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  2. Global Hormone Receptor, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  3. Global HER2+, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  4. Global Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  5. Global Targeted Therapy, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  6. Global Hormonal Therapy, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  7. Global Surgery and Radiation Therapy, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  8. Global Biologic Therapy, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  9. Global Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  10. Global Hospital Pharmacies, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  11. Global Retail Pharmacies, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  12. Global Online Pharmacies, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  13. Global Others, Breast Cancer Market, By Region, 2022-2032(USD Billion)
  14. Global Breast Cancer Market, By Region, 2022-2032(USD Billion)
  15. North America Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  16. North America Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  17. North America Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  18. U.S. Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  19. U.S. Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  20. U.S. Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  21. Canada Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  22. Canada Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  23. Canada Breast Cancer Market, Distribution Channel, 2022-2032(USD Billion)
  24. Mexico Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  25. Mexico Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  26. Mexico Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  27. Europe Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  28. Europe Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  29. Europe Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  30. Germany Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  31. Germany Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  32. Germany Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  33. France Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  34. France Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  35. France Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  36. U.K. Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  37. U.K. Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  38. U.K. Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  39. Italy Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  40. Italy Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  41. Italy Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  42. Spain Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  43. Spain Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  44. Spain Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  45. Asia Pacific Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  46. Asia Pacific Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  47. Asia Pacific Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  48. Japan Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  49. Japan Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  50. Japan Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  51. China Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  52. China Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  53. China Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  54. India Breast Cancer Market, By Cancer Type, 2022-2032(USD Billion)
  55. India Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  56. India Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  57. South America Breast Cancer Market, Cancer Type, 2022-2032(USD Billion)
  58. South America Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  59. South America Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  60. Brazil Breast Cancer Market, Cancer Type, 2022-2032(USD Billion)
  61. Brazil Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  62. Brazil Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)
  63. The Middle East and Africa Breast Cancer Market, Cancer Type, 2022-2032(USD   Billion)
  64. The Middle East and Africa Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  65. The Middle East and Africa Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)  
  66. UAE Breast Cancer Market, Cancer Type, 2022-2032(USD Billion)
  67. UAE Breast Cancer Market, By Therapy, 2022-2032(USD Billion) 
  68. UAE Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion) 
  69. South Africa Breast Cancer Market, Cancer Type, 2022-2032(USD Billion)
  70. South Africa Breast Cancer Market, By Therapy, 2022-2032(USD Billion)
  71. South Africa Breast Cancer Market, By Distribution Channel, 2022-2032(USD Billion)

List of Figures 

  1. Global Breast Cancer Market Segmentation
  2. Breast Cancer Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Breast Cancer Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Breast Cancer Market
  20. Breast Cancer Market Segmentation, By Cancer Type
  21. Breast Cancer Market, For Hormone Receptor, By Region, 2022-2032 ($ Billion)
  22. Breast Cancer Market, For HER2+, By Region, 2022-2032 ($ Billion)
  23. Breast Cancer Market Segmentation, By Therapy
  24. Breast Cancer Market, For Targeted Therapy, By Region, 2022-2032 ($ Billion)
  25. Breast Cancer Market, For Hormonal Therapy, By Region, 2022-2032 ($ Billion)
  26. Breast Cancer Market, For Surgery and Radiation Therapy, By Region, 2022-2032 ($ Billion)
  27. Breast Cancer Market, For Biologic Therapy, By Region, 2022-2032 ($ Billion)
  28. Breast Cancer Market Segmentation, By Distribution Channel
  29. Breast Cancer Market, For Hospital Pharmacies, By Region, 2022-2032 ($ Billion)
  30. Breast Cancer Market, For Retail Pharmacies, By Region, 2022-2032 ($ Billion)
  31. Breast Cancer Market, For Online Pharmacies, By Region, 2022-2032 ($ Billion)
  32. Breast Cancer Market, For Others, By Region, 2022-2032 ($ Billion)
  33. Bristol Myers Squiib: Net Sales, 2022-2032 ($ Billion)
  34. Bristol Myers Squiib: Revenue Share, By Segment, 2022 (%)
  35. Bristol Myers Squiib: Revenue Share, By Region, 2022 (%)
  36. KYOWA KIRIN: Net Sales, 2022-2032 ($ Billion)
  37. KYOWA KIRIN: Revenue Share, By Segment, 2022 (%)
  38. KYOWA KIRIN: Revenue Share, By Region, 2022 (%)
  39. Mylan Laboratories Inc: Net Sales, 2022-2032 ($ Billion)
  40. Mylan Laboratories Inc: Revenue Share, By Segment, 2022 (%)
  41. Mylan Laboratories Inc: Revenue Share, By Region, 2022 (%)
  42. Bausch Health Companies Inc: Net Sales, 2022-2032 ($ Billion)
  43. Bausch Health Companies Inc: Revenue Share, By Segment, 2022 (%)
  44. Bausch Health Companies Inc: Revenue Share, By Region, 2022 (%)
  45. Pfizer Inc: Net Sales, 2022-2032 ($ Billion)
  46. Pfizer Inc: Revenue Share, By Segment, 2022 (%)
  47. Pfizer Inc: Revenue Share, By Region, 2022 (%)
  48. Baxter International, Inc: Net Sales, 2022-2032 ($ Billion)
  49. Baxter International, Inc: Revenue Share, By Segment, 2022 (%)
  50. Baxter International, Inc: Revenue Share, By Region, 2022 (%)
  51. Eli Lilly and Company: Net Sales, 2022-2032 ($ Billion)
  52. Eli Lilly and Company: Revenue Share, By Segment, 2022 (%)
  53. Eli Lilly and Company: Revenue Share, By Region, 2022 (%)
  54. Genentech: Net Sales, 2022-2032 ($ Billion)
  55. Genentech: Revenue Share, By Segment, 2022 (%)
  56. Genentech: Revenue Share, By Region, 2022 (%)
  57. Mylan Laboratories: Net Sales, 2022-2032 ($ Billion)
  58. Mylan Laboratories: Revenue Share, By Segment, 2022 (%)
  59. Mylan Laboratories: Revenue Share, By Region, 2022 (%)
  60. Celltrion.: Net Sales, 2022-2032 ($ Billion)
  61. Celltrion.: Revenue Share, By Segment, 2022 (%)
  62. Celltrion.: Revenue Share, By Region, 2022 (%)
  63. Fresenius Kabi: Net Sales, 2022-2032 ($ Billion)
  64. Fresenius Kabi: Revenue Share, By Segment, 2022 (%)
  65. Fresenius Kabi: Revenue Share, By Region, 2022 (%)
  66. Baxter Healthcare Corporation: Net Sales, 2022-2032 ($ Billion)
  67. Baxter Healthcare Corporation: Revenue Share, By Segment, 2022 (%)
  68. Baxter Healthcare Corporation: Revenue Share, By Region, 2022 (%)
  69. Halozyme Inc: Net Sales, 2022-2032 ($ Billion)
  70. Halozyme Inc: Revenue Share, By Segment, 2022 (%)
  71. Halozyme Inc: Revenue Share, By Region, 2022 (%)
  72. GlaxoSmithKline: Net Sales, 2022-2032 ($ Billion)
  73. GlaxoSmithKline: Revenue Share, By Segment, 2022 (%)
  74. GlaxoSmithKline: Revenue Share, By Region, 2022 (%)
  75. AstraZeneca: Net Sales, 2022-2032 ($ Billion)
  76. AstraZeneca: Revenue Share, By Segment, 2022 (%)
  77. AstraZeneca: Revenue Share, By Region, 2022 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies